4800 Friendship Avenue, Pittsburgh, PA, 15224 · (412) 578-5000
Beds
255
FY 2025
Star rating
3 of 5
Patient survey: 4 of 5
Net patient revenue
$923.3M
FY 2025
Net income
$223.4M
Patient care margin 13.6%
Discharges
11,309
Occupancy 78.5%
Clinicians
1,050
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $923.3M | $798.1M | 13.6% | $223.4M | 11,309 | $4.5M | 8.6% | 1.9% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for heart attack patients | 11% | US median 11.8% |
| Death rate for heart failure patients | 9.8% | US median 11% |
| Hospital-wide death rate within 30 days | 3.2% | US median 3.9% |
| Death rate for pneumonia patients | 16% | US median 15.2% |
| Death rate for stroke patients | 11.8% | US median 11.6% |
| Readmission rate for COPD | 19.8% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $897.4M | $761.2M | 15.2% | $191.7M | 10,913 | $4.1M | 9.1% | 2.1% |
| 2023 | $776.4M | $690.4M | 11.1% | $146.3M | 13,763 | $3.4M | 10.4% | 2.5% |
| 2022 | $684.2M | $627.5M | 8.3% | $101.5M | 13,783 | $2.8M | 9.8% | 2.4% |
| 2021 | $686.8M | $567.4M | 17.4% | $154.4M | 15,016 | $3.2M | 10.3% | 2.4% |
| 2020 | $618.4M | $506.9M | 18.0% | $148.9M | 15,589 | $2.2M | 9.1% | 3.0% |
| US median 19.8% |
| Readmission rate after a heart attack | 13.6% | US median 14.4% |
| Readmission rate for heart failure | 20.9% | US median 21.3% |
| Readmission rate for pneumonia | 17.2% | US median 17.2% |
| Serious complications (patient safety composite) | 1.06 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.30 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.47 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 1.58 | US median 0.72 |
| Surgical site infections after hysterectomy (ratio to expected) | 0.60 | US median 0.81 |
| MRSA bloodstream infections (ratio to expected) | 0.52 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.48 | US median 0.40 |
| Doctors always communicated well | 79% | US median 79% |
| Nurses always communicated well | 85% | US median 80% |
| Patient survey summary star rating | 4 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 58% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 76% | US median 72% |
| Room and bathroom always clean | 72% | US median 73% |
| Patients who would definitely recommend the hospital | 77% | US median 71% |
| Patients who left the emergency department before being seen | 2% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 208 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 11% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 60% | US median 65% |
| Healthcare workers given the flu vaccine | 50% | US median 79% |
| 27 |
| $65,456.15 |
| $9,163.63 |
| $10,022.34 |
| DRG 840 LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC | 20 | $176,214.35 | $24,823.10 | $33,608.85 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 18 | $88,519.44 | $11,039.61 | $9,867.73 |
| DRG 847 CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC | 17 | $80,595.18 | $11,847.24 | $12,158.78 |
| DRG 392 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | 17 | $35,510.59 | $5,635.06 | $5,662.18 |
| DRG 683 RENAL FAILURE WITH CC | 17 | $47,674.41 | $6,370.24 | $6,629.69 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 15 | $183,087.20 | $38,011.73 | $40,556.82 |
| DRG 331 MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT CC/MCC | 15 | $74,599.20 | $11,214.73 | $12,052.70 |
| DRG 328 STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITHOUT CC/MCC | 14 | $54,014.07 | $11,356.43 | $12,768.14 |
| DRG 389 GASTROINTESTINAL OBSTRUCTION WITH CC | 14 | $40,698.86 | $5,653.29 | $5,697.23 |
| DRG 834 ACUTE LEUKEMIA WITH MCC | 14 | $426,675.07 | $66,052.86 | $63,231.97 |
| DRG 326 STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH MCC | 13 | $223,090.08 | $36,107.08 | $46,606.17 |
| DRG 391 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MCC | 13 | $71,240.92 | $7,297.54 | $10,202.94 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5302 Level 2 Upper GI Procedures | 228 | 189 | $1,308.11 | $1,444.50 |
| APC 8011 Comprehensive Observation Services | 134 | 117 | $1,904.26 | $2,090.36 |
| APC 5362 Level 2 Laparoscopy and Related Services | 101 | 101 | $7,256.91 | $8,164.45 |
| APC 5414 Level 4 Gynecologic Procedures | 78 | 78 | $2,181.92 | $2,389.24 |
| APC 5373 Level 3 Urology and Related Services | 78 | 47 | $1,194.84 | $1,516.28 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 65 | 56 | $1,990.96 | $2,141.49 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 63 | 62 | $1,138.57 | $1,219.56 |
| APC 5183 Level 3 Vascular Procedures | 60 | 58 | $2,230.49 | $2,405.01 |
| APC 5361 Level 1 Laparoscopy and Related Services | 56 | 56 | $3,886.09 | $4,357.80 |
| APC 5191 Level 1 Endovascular Procedures | 52 | 52 | $2,005.19 | $2,207.96 |
| APC 5372 Level 2 Urology and Related Services | 49 | 24 | $337.77 | $502.15 |
| APC 5092 Level 2 Breast/Lymphatic Surgery and Related Procedures | 37 | 36 | $4,640.58 | $4,981.95 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 2 | $136K |
| Olympus America Inc. | 2 | $7,865 |
| Aesculap, Inc. | 1 | $159 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
West Penn Hospital is a nonprofit short-term acute care hospital in Pittsburgh, PA with 255 beds, part of Allegheny Health Network and a 3-star overall rating.
West Penn Hospital in Pittsburgh, PA has 255 beds (fiscal year 2025 cost report); 311 beds are certified for Medicare. It discharged 11,309 inpatients that year, with 78.5% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), West Penn Hospital reported net patient revenue of $923.3M and operating expenses of $798.1M, a margin on patient care of 13.6%. After other income and expenses its net income was $223.4M (21.9% of revenue), so it made a profit that year.
West Penn Hospital is part of Allegheny Health Network, a health system with 6 hospitals based in Pittsburgh, PA. It is a nonprofit hospital.
West Penn Hospital has an overall rating of 3 out of 5 stars in the official hospital quality ratings. Patients rate it 4 out of 5 stars in the patient survey.
Yes, West Penn Hospital provides emergency services.
1,050 Medicare clinicians list West Penn Hospital as a hospital they work at, most often in Physician Assistant, Internal Medicine, Nurse Practitioner.
In 2024, West Penn Hospital had 415 Medicare inpatient stays in 26 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 37 stays; Medicare paid $15,841.54 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $144K in payments to West Penn Hospital as a teaching hospital ($8,024 general and $136K for research) from 3 companies.